We report two children with hemihypertrophy and Chiari I malformation (CIM) and review the extant medical literature regarding CIM and overgrowth disorders. We propose that these two entities do not represent a spurious association but rather share a common dysembryology of mesoderm.

Oakes WJ, Tubbs RS: Chiari malformations; in Winn HR (ed): Youman’s Neurological Surgery: A Comprehensive Guide to the Diagnosis and Management of Neurological Problems, ed 5. Philadelphia, WB Saunders, in press.
Gorlin RJ: Proteus syndrome. J Clin Dysmorphol 1984;2:8–9.
Viljoen DL: Klippel-Trenaunay-Weber syndrome (angio-macroglossia-gigantism syndrome). J Med Genet 1988;25:250–252.
Schwärzler P, Homfray T, Campbell S, Ville Y: Prenatal findings on ultrasound and X-ray in a case of overgrowth syndrome associated with increased nuchal translucency. Prenat Diagn 2001;21:341–345.
Rowe NH: Hemifacial hypertrophy: Review of the literature and addition of four cases. Oral Surg 1962;15:572–587.
Gorlin RJ, Meskin LH: Congenital hemihypertrophy: Review of the literature and report of a case with special emphasis on oral manifestations. J Pediatr 1962;61:870–879.
Ringrose RE, Jabbour JT, Keele DK: Hemihypertrophy. Pediatrics 1965;36:434–448.
Amitai DB, Fichman S, Merlob P, Morad Y, Lapidoth M, Metzker A: Cutis marmorata telangiectatica congenita: Clinical findings in 85 patients. Pediatr Dermatol 2000;17:100–104.
Carcao M, Blaser SI, Grant RM, Weksberg R, Siegel-Bartelt J: MRI findings in macrocephaly-cutis marmorata telangiectatica congenita. Am J Med Genet 1998;76:165–167.
Thong MK, Thompson E, Keenan R, Simmer K, Harbord M, Davidson G, Haan E: A child with hemimegalencephaly, hemihypertrophy, macrocephaly, cutaneous vascular malformation, psychomotor retardation and intestinal lymphangiectasia – a diagnostic dilemma. Clin Dysmorphol 1999;8:283–286.
Happle R: Cutaneous manifestations of lethal genes. Hum Genet 1986;72:280.
Jaubert J, Jaubert F, Martin N, Washburn LL, Lee BK, Eicher EM, Guenet JL: Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene (Npr3). Proc Natl Acad Sci USA 1999;96:10278–10283.
Badie B, Mendoza BA, Batzdorf U: Posterior fossa volume and response to suboccipital decompression in patients with Chiari I malformation. Neurosurgery 1995;37:214–218.
Milhorat TH, Chou MW, Trinidad EM, Kula RW, Mandell M, Wolpert C, Speer MC: Chiari I malformation redefined: Clinical and radiographic findings for 364 symptomatic patients. Neurosurgery 1999;44:1005–1017.
Nishikawa M, Sakamoto H, Hakuba A, Nakanishi N, Inoue Y: Pathogenesis of Chiari malformation: A morphometric study of the posterior cranial fossa. J Neurosurg 1997;86:40–47.
Nyland H, Krogness KG: Size of posterior fossa in Chiari type 1 malformation in adults. Acta Neurochir (Wien) 1978;40:233–242.
Schady W, Metcalfe RA, Butler P: The incidence of craniocervical bony anomalies in the adult Chiari malformation. J Neurol Sci 1987;82:193–203.
Vega A, Quintana F, Berciano J: Basichondrocranium anomalies in adult Chiari type I malformation: A morphometric study. J Neurol Sci 1990;99:137–145.
Tubbs RS, Elton S, Grabb P, Bartolucci A, Oakes WJ: Analysis of the posterior fossa in children with the Chiari 0 malformation. Neurosurgery 2001;48:1050–1055.
Cinalli G, Renier D, Sebag G, Sainte-Rose C, Arnaud E, Pierre-Kahn A: Chiari ‘malformation’ in Crouzon syndrome. Arch Pediatr 1996;3:433–439.
Martinez-Perez D, Vander Woude DL, Barnes PD, Scott RM, Mulliken JB: Jugular foraminal stenosis in Crouzon syndrome. Pediatr Neurosurg 1996;25:252–255.
Lapresle J, Métreau R, Risvegliato M: Hypertrophie musculaire segmentaire au cours d’une malformation d’Arnold-Chiari associée a un syndrome syringomyélique. Rev Neurol (Paris) 1976;132:567–570.
Caldemeyer KS, Boaz JC, Wappner RS, Moran CC, Smith RR, Quets JP: Chiari I malformation: Association with hypophosphatemic rickets and MR imaging appearance. Radiology 1995;195:602–604.
Mesiwala AH, Shaffrey CI, Gruss JS, Ellenbogen RG: Atypical hemifacial microsomia associated with Chiari I malformation and syrinx: Further evidence indicating that Chiari I malformation is a disorder of paraxial mesoderm. J Neurosurg 2001;95:1034–1039.
Sze RW, Gruss JS, Cunningham ML: Unilateral aplasia of the middle cranial fossa floor in atypical hemifacial microsomia. AJNR Am J Neuroradiol 2001;22:1434–1437.
Russell LJ, Weaver DD, Bull MJ: The axial mesodermal dysplasia spectrum. Pediatrics 1981;67:176–182.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.